FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). (Q54435146)
Jump to navigation
Jump to search
scientific article published in August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). |
scientific article published in August 2007 |
Statements
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). (English)
1 reference
Patricia Anne Dinndorf
1 reference
Joseph Gootenberg
1 reference
Martin H Cohen
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
1 August 2007
1 reference
1 reference
12
1 reference
991-998
1 reference
8
1 reference
Identifiers
1 reference